Physician profile
Allison Andreas
NPI 1972007250
$4,785.32
in general payments reported to CMS, 2019-2025
32 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $1,252 · 2023: $834 · 2024: $732 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470 · Travel and Lodging: $346 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.54 |
| Travel and Lodging | $346.05 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $702.12 | 2021-2025 | Repatha, Repatha |
| Atricure, INC. | $538.62 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novo Nordisk INC | $525.32 | 2022-2025 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.13 | 2021-2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $295.89 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $263.33 | 2021-2024 | Xarelto |
| Abbott Laboratories | $226.73 | 2021-2025 | Coroflow, Cardiomems, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $187.39 | 2024-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $173.95 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.51 | 2022-2025 | Jardiance |
| Esperion Therapeutics, INC. | $138.19 | 2021 | |
| Pfizer INC. | $137.60 | 2022-2025 | |
| Shockwave Medical, INC | $129.37 | 2025 | |
| Merck Sharp & Dohme LLC | $126.75 | 2024-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $121.55 | 2022-2023 | Optimizer |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $117.43 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $90.65 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $90.49 | 2021-2025 | Farxiga |
| Boston Scientific Corporation | $70.51 | 2023 | Watchman, Watchman Access System |
| Itamar Medical INC | $58.90 | 2022 | |
| Cvrx, INC. | $47.41 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $40.93 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $29.98 | 2022 | |
| Abiomed | $25.54 | 2024 | Impella |
| Glaxosmithkline, LLC. | $24.86 | 2025 | Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $23.01 | 2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $19.33 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.44 | 2023 | Inpefa |
| Bardy Diagnostics, INC. | $16.74 | 2022 | |
| Scpharmaceuticals INC. | $14.10 | 2025 | |
| Sanofi-Aventis U.S. LLC | $12.48 | 2022 | |
| Chiesi USA, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Andreas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.